• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学创新与成本控制相互较量。

Medical innovation duels cost containment.

作者信息

Rettig R A

出版信息

Health Aff (Millwood). 1994 Summer;13(3):7-27. doi: 10.1377/hlthaff.13.3.7.

DOI:10.1377/hlthaff.13.3.7
PMID:7927162
Abstract

The nation's commitment to health cost control will potentially conflict with its deeper commitment to innovation in medical technology--drugs, medical devices, diagnostic and therapeutic procedures, and administrative infrastructure. Medical technology is implicated in increasing health care costs because, on a net basis, it increases the capabilities of medicine. Conceptual, methodological, institutional, and political factors limit the ability to address the potential conflict; these limits must be confronted and addressed if we are to formulate sound policy responses.

摘要

国家对医疗成本控制的承诺可能会与其对医疗技术创新(药物、医疗设备、诊断和治疗程序以及管理基础设施)的更深层次承诺产生冲突。医疗技术与医疗保健成本增加有关,因为从总体上看,它提高了医疗能力。概念、方法、制度和政治因素限制了应对潜在冲突的能力;如果我们要制定合理的政策应对措施,就必须正视并解决这些限制因素。

相似文献

1
Medical innovation duels cost containment.医学创新与成本控制相互较量。
Health Aff (Millwood). 1994 Summer;13(3):7-27. doi: 10.1377/hlthaff.13.3.7.
2
Innovation under federal health care reform.联邦医疗保健改革下的创新。
Health Aff (Millwood). 1994 Summer;13(3):82-97. doi: 10.1377/hlthaff.13.3.82.
3
The dynamics of technological change in medicine.医学领域技术变革的动态
Health Aff (Millwood). 1994 Summer;13(3):28-46. doi: 10.1377/hlthaff.13.3.28.
4
Paying for miracles.为奇迹买单。
Natl J (Wash). 1993 Aug 7;25(32):1967-71.
5
Health care technology assessment--the South African health care system in transition.
S Afr Med J. 1999 Feb;89(2):149-55.
6
Cost escalation in health-care technology--possible solutions.
S Afr Med J. 1993 Jun;83(6):420-2.
7
Slowing the growth of health care costs--learning from international experience.减缓医疗保健成本的增长——借鉴国际经验。
N Engl J Med. 2008 Oct 23;359(17):1751-5. doi: 10.1056/NEJMp0805261.
8
The impact of technology on health care costs.技术对医疗保健成本的影响。
Profile Med Pract. 1980:107-21.
9
Preserving the milieu for medical innovation.
Health Aff (Millwood). 1994 Summer;13(3):112-4. doi: 10.1377/hlthaff.13.3.112.
10
The rising cost of healthcare. Cost increases drive healthcare to the top of the domestic policy agenda.医疗保健成本不断上升。成本增加将医疗保健推上了国内政策议程的首要位置。
Healthc Exec. 2003 Mar-Apr;18(2):70-1.

引用本文的文献

1
Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs.医生对成本控制政策的承诺及长期有效性:从生物类似药中吸取的教训
Clinicoecon Outcomes Res. 2015 Nov 11;7:575-81. doi: 10.2147/CEOR.S88531. eCollection 2015.
2
Medical technology as a key driver of rising health expenditure: disentangling the relationship.医疗技术作为医疗支出增长的关键驱动因素:理清两者关系。
Clinicoecon Outcomes Res. 2013 May 30;5:223-34. doi: 10.2147/CEOR.S39634. Print 2013.
3
The quality of medical care, behavioral risk factors, and longevity growth.
医疗保健质量、行为风险因素与寿命增长。
Int J Health Care Finance Econ. 2011 Mar;11(1):1-34. doi: 10.1007/s10754-010-9086-y. Epub 2010 Dec 25.
4
Healthcare costs for new technologies.
Eur J Nucl Med Mol Imaging. 2009 Mar;36 Suppl 1:S139-43. doi: 10.1007/s00259-008-0975-y.
5
The emergence of clinical practice guidelines.临床实践指南的出现。
Milbank Q. 2007 Dec;85(4):691-727. doi: 10.1111/j.1468-0009.2007.00505.x.
6
The societal value of pharmaceuticals. Balancing industrial and healthcare policy.药品的社会价值。平衡产业政策与医疗政策。
Pharmacoeconomics. 1996 Jul;10(1):14-22. doi: 10.2165/00019053-199610010-00003.
7
Osler meets the marketplace--speculations on the future of internal medicine in the 21st century.奥斯勒与市场——对21世纪内科医学未来的思考
Trans Am Clin Climatol Assoc. 1996;107:249-60; discussion 260-2.